Detalhe da pesquisa
1.
Trametinib versus standard of care in patients with recurrent low-grade serous ovarian cancer (GOG 281/LOGS): an international, randomised, open-label, multicentre, phase 2/3 trial.
Lancet
; 399(10324): 541-553, 2022 02 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35123694
2.
A phase II evaluation of temsirolimus with carboplatin and paclitaxel followed by temsirolimus consolidation in clear cell ovarian cancer: An NRG oncology trial.
Gynecol Oncol
; 167(3): 423-428, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36244829
3.
Red blood cell fatty acids and age-related macular degeneration in postmenopausal women.
Eur J Nutr
; 61(3): 1585-1594, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34988653
4.
Phase II study of axalimogene filolisbac (ADXS-HPV) for platinum-refractory cervical carcinoma: An NRG oncology/gynecologic oncology group study.
Gynecol Oncol
; 158(3): 562-569, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32641240
5.
Findings from Optometrists' Practices in Advising about Lifestyle Study.
Optom Vis Sci
; 97(8): 598-605, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32833404
6.
An international, phase III randomized trial in patients with mucinous epithelial ovarian cancer (mEOC/GOG 0241) with long-term follow-up: and experience of conducting a clinical trial in a rare gynecological tumor.
Gynecol Oncol
; 153(3): 541-548, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31005287
7.
Clinical trial methodology in rare gynecologic tumor research: Strategies for success.
Gynecol Oncol
; 149(3): 605-611, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29699802
8.
Phase II study of single-agent cabozantinib in patients with recurrent clear cell ovarian, primary peritoneal or fallopian tube cancer (NRG-GY001).
Gynecol Oncol
; 150(1): 9-13, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29739622
9.
A Phase I Evaluation of Extended Field Radiation Therapy With Concomitant Cisplatin Chemotherapy Followed by Paclitaxel and Carboplatin Chemotherapy in Women With Cervical Carcinoma Metastatic to the Para-aortic Lymph Nodes: An NRG Oncology/Gynecologic Oncology Group Study.
Gynecol Oncol
; 151(2): 202-207, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30174176
10.
Is carboplatin-based chemotherapy as effective as cisplatin-based chemotherapy in the treatment of advanced-stage dysgerminoma in children, adolescents and young adults?
Gynecol Oncol
; 150(2): 253-260, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29884437
11.
A phase I trial of intraperitoneal GEN-1, an IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer, administered with pegylated liposomal doxorubicin in patients with recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal cancers: An NRG Oncology/Gynecologic Oncology Group study.
Gynecol Oncol
; 147(2): 283-290, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28802766
12.
An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience.
Gynecol Oncol
; 147(2): 243-249, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28807367
13.
A phase I pharmacokinetic study of intraperitoneal bortezomib and carboplatin in patients with persistent or recurrent ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study.
Gynecol Oncol
; 145(2): 236-242, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28341300
14.
Is adjuvant chemotherapy indicated in ovarian immature teratomas? A combined data analysis from the Malignant Germ Cell Tumor International Collaborative.
Cancer
; 122(2): 230-7, 2016 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26485622
15.
The role of racial genetic admixture with endometrial cancer outcomes: An NRG Oncology/Gynecologic Oncology Group study.
Gynecol Oncol
; 140(2): 264-9, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26603970
16.
A phase I trial of pegylated liposomal doxorubicin (PLD), carboplatin, bevacizumab and veliparib in recurrent, platinum-sensitive ovarian, primary peritoneal, and fallopian tube cancer: An NRG Oncology/Gynecologic Oncology Group study.
Gynecol Oncol
; 140(2): 204-9, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26616225
17.
Minority participation in Gynecologic Oncology Group (GOG) Studies.
Gynecol Oncol
; 138(2): 441-4, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26013697
18.
Efficacy and safety of bevacizumab in recurrent sex cord-stromal ovarian tumors: results of a phase 2 trial of the Gynecologic Oncology Group.
Cancer
; 120(3): 344-51, 2014 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24166194
19.
A phase II evaluation of pazopanib in the treatment of recurrent or persistent carcinosarcoma of the uterus: a gynecologic oncology group study.
Gynecol Oncol
; 133(3): 537-41, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24594074
20.
Histologic effects of medroxyprogesterone acetate on endometrioid endometrial adenocarcinoma: a Gynecologic Oncology Group study.
Int J Gynecol Pathol
; 33(6): 543-53, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25272292